What is abiraterone 250mg Tablet?
abiraterone 250mg Tablet is a hormonal treatment, not a chemotherapy drug. It is used to treat prostate cancer in adult men that has spread to other parts of the body. Alkeprost 250mg Tablet stops your body from making testosterone. This can slow down the growth of prostate cancer.
Common Side Effects of Abiraterone 250mg Tablet Alkeprost.
The most common side effects of this medicine, Abiraterone 250mg Tablet Alkeprost, include vomiting, Decreased potassium level in the blood, edema (swelling), decreased white blood cell count, fatigue, and increased liver enzymes. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Other than this, yellowing of the skin, loss of appetite, shortness of breath, dark urine, and nausea can happen, which indicates some liver problems. Your doctor might check you for liver function, blood pressure, and the level of potassium in your blood.
Precautions:-
Alkeprost 250mg Tablet should not be taken on an empty stomach. Taking it with food may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to….Read more
Trade Name: Alkeprost
Manufacturer: Alkem Laboratories
Presentation: Tablet
Strength: 250mg
We are exporting medicines to the Cayman Islands, Columbia, Dominica, UAE, Oman, Russia, Chile, Indonesia, Philippines, Peru, Bolivia, Ecuador, Haiti, Nicaragua, etc. If you are looking for another product or brand click here. The following information is meant for Wholesalers, Suppliers, Exporters, Doctors, CROs, Comparator Supplies, Hospitals, MOH Tender Supplies, Generic, Brand, Cooperate Sourcing, India, and Institutional Buyers.
